Literature DB >> 17488326

Predominance of SHV-5 beta-lactamase in enteric bacteria causing community-acquired urinary tract infections in Bosnia and Herzegovina.

S Uzunovic-Kamberovic1, B Bedenic, J Vranes.   

Abstract

The beta-lactamases produced by 14 non-duplicate Klebsiella pneumoniae isolates and five Escherichia coli isolates from urine samples obtained from outpatients were characterised by isoelectric focusing, substrate profile determination, PCR and sequencing of bla(SHV) genes. Three E. coli A15 R(+) transconjugants were identified as isolates that produced SHV-5 beta-lactamase. This report is the first description of SHV-5 beta-lactamase among community isolates. Since the isolates showed distinct pulsed-field gel electrophoresis patterns, it was concluded that there was no clonal spread of bla(TEM) and bla(SHV) genes, and that dissemination of the bla(TEM) and bla(SHV) genes was the result of exchange of plasmids among different clones.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488326     DOI: 10.1111/j.1469-0691.2007.01747.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  2 in total

1.  Characterization of the extended-spectrum β-lactamases and determination of the virulence factors of uropathogenic Escherichia coli strains isolated from children.

Authors:  Branka Bedenić; Jasmina Vraneš; Sabine Hofmann-Thiel; Marija Tonkić; Anita Novak; Viljemka Bučević-Popovic; Harald Hoffmann
Journal:  Wien Klin Wochenschr       Date:  2012-08-16       Impact factor: 1.704

2.  Emergency (clonal spread) of methicillin-resistant Staphylococcus aureus (MRSA), extended spectrum (ESBL)--and AmpC beta-lactamase-producing Gram-negative bacteria infections at Pediatric Department, Bosnia and Herzegovina.

Authors:  Selma Uzunović; Branka Bedenić; Ana Budimir; Farah Kamberović; Amir Ibrahimagić; Sabina Delić-Bikić; Sara Sivec; Tomislav Meštrović; Dijana Varda Brkić; Michelle I A Rijnders; Ellen E Stobberingh
Journal:  Wien Klin Wochenschr       Date:  2014-09-06       Impact factor: 1.704

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.